PACS Group, Inc. — Form 8-K
Filed November 3, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 68/100
What the filing says
Q3 2026 revenue reached $1.50 billion (11.5% YoY increase); net income grew 16.2% to $60.8 million; Adjusted EBITDA jumped 33.6% to $175.7 million. Company deployed $213 million on M&A in Q3 and $403.8 million YTD, closing 11 Texas facilities (4,049 SNF beds) and 32 Florida facilities (entry into new state) on Oct 1, 2026. Full-year 2026 guidance raised: Adjusted EBITDA now $685–695 million (prior $640–660 million); revenue $5.95–6.05 billion (prior $5.75–5.85 billion). Same-store SNF revenue +6.4% YoY; occupancy improved to 91.3% (vs. 89.3% prior year); 78.9% of facilities rated 4–5 stars by CMS.
Why this rating
Strong YoY growth (11.5% revenue, 33.6% Adj. EBITDA), raised guidance, $403.8M M&A YTD (~69% of market cap). Geographic expansion into Florida and Texas is meaningful. Operating metrics solid. Positive but execution and integration risks remain.
See more from November 3, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.